| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 11 1195-1203, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
DK Ways, K Posekany, J deVente, T Garris, J Chen, J Hooker, W Qin, P Cook, D Fletcher and P Parker
Department of Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858-4354.
A function for protein kinase C-zeta (PKC-zeta), a member of the phorbol ester nonresponsive atypical protein kinase C subfamily, in modulating differentiation was examined in the leukemic U937 cell. Transfected U937 cells stably overexpressing PKC-zeta displayed a longer doubling time, lower saturation density at confluency, and an increase in adherence to plastic as compared to control cells. PKC-zeta cells expressed a more differentiated phenotype as assessed by changes in morphology, surface antigen expression, and lysosomal enzyme activities and were distinct from parental U937 cells stimulated to differentiate by exposure to phorbol esters. In contrast to parental U937 cells, PKC-zeta cells constitutively expressed mRNA transcripts for c-jun and a low mobility AP-1 binding activity. Thus, PKC-zeta overexpression stimulates a type of phenotypic differentiation that differs significantly from maturation occurring upon activation of other PKC subfamilies induced by phorbol ester treatment. Increased expression of the c-jun protooncogene and an increase in AP-1 binding activity in PKC-zeta cells provides a potential mechanism for explaining the altered differentiation status of this cell.
This article has been cited by other articles:
![]() |
L. Leseux, G. Laurent, C. Laurent, M. Rigo, A. Blanc, D. Olive, and C. Bezombes PKC {zeta} mTOR pathway: a new target for rituximab therapy in follicular lymphoma Blood, January 1, 2008; 111(1): 285 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jones, R. E. Stroud, B. S. Kaplan, A. M. Leone, J. E. Bavaria, J. H. Gorman III, R. C. Gorman, and J. S. Ikonomidis Differential Protein Kinase C Isoform Abundance in Ascending Aortic Aneurysms From Patients With Bicuspid Versus Tricuspid Aortic Valves Circulation, September 11, 2007; 116(11_suppl): I-144 - I-149. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mustafi, S. Cerda, A. Chumsangsri, A. Fichera, and M. Bissonnette Protein Kinase-{zeta} Inhibits Collagen I-Dependent and Anchorage-Independent Growth and Enhances Apoptosis of Human Caco-2 Cells Mol. Cancer Res., September 1, 2006; 4(9): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Esteve, E. Chicoine, O. Robledo, F. Aoudjit, A. Descoteaux, E. F. Potworowski, and Y. St-Pierre Protein Kinase C-zeta Regulates Transcription of the Matrix Metalloproteinase-9 Gene Induced by IL-1 and TNF-alpha in Glioma Cells via NF-kappa B J. Biol. Chem., September 13, 2002; 277(38): 35150 - 35155. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Plo, H. Hernandez, G. Kohlhagen, D. Lautier, Y. Pommier, and G. Laurent Overexpression of the Atypical Protein Kinase C zeta Reduces Topoisomerase II Catalytic Activity, Cleavable Complexes Formation, and Drug-induced Cytotoxicity in Monocytic U937 Leukemia Cells J. Biol. Chem., August 23, 2002; 277(35): 31407 - 31415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Procyk, M. R. Rippo, R. Testi, F. Hofmann, P. J. Parker, and M. Baccarini Lipopolysaccharide induces Jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C Blood, October 1, 2000; 96(7): 2592 - 2598. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Procyk, M. R. Rippo, R. Testi, F. Hoffmann, P. J. Parker, and M. Baccarini Distinct Mechanisms Target Stress and Extracellular Signal-Activated Kinase 1 and Jun N-Terminal Kinase During Infection of Macrophages with Salmonella J. Immunol., November 1, 1999; 163(9): 4924 - 4930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Oskeritzian, Z. Wang, J. P. Kochan, M. Grimes, Z. Du, H.-W. Chang, S. Grant, and L. B. Schwartz Recombinant Human (rh)IL-4-Mediated Apoptosis and Recombinant Human IL-6-Mediated Protection of Recombinant Human Stem Cell Factor-Dependent Human Mast Cells Derived from Cord Blood Mononuclear Cell Progenitors J. Immunol., November 1, 1999; 163(9): 5105 - 5115. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. H. Whelan, S. C. Kiley, and P. J. Parker Tetradecanoyl Phorbol Acetate-induced Microtubule Reorganization Is Required for Sustained Mitogen-activated Protein Kinase Activation and Morphological Differentiation of U937 Cells Cell Growth Differ., April 1, 1999; 10(4): 271 - 277. [Abstract] [Full Text] |
||||
![]() |
Y. Izumi, T. Hirose, Y. Tamai, S.-i. Hirai, Y. Nagashima, T. Fujimoto, Y. Tabuse, K. J. Kemphues, and S. Ohno An Atypical PKC Directly Associates and Colocalizes at the Epithelial Tight Junction with ASIP, a Mammalian Homologue of Caenorhabditis elegans Polarity Protein PAR-3 J. Cell Biol., October 5, 1998; 143(1): 95 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ragg, S. Kaga, K. A. Berg, and A. Ochi The Mitogen-Activated Protein Kinase Pathway Inhibits Ceramide-Induced Terminal Differentiation of a Human Monoblastic Leukemia Cell Line, U937 J. Immunol., August 1, 1998; 161(3): 1390 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanchez, G. De Carcer, I. V. Sandoval, J. Moscat, and M. T. Diaz-Meco Localization of Atypical Protein Kinase C Isoforms into Lysosome-Targeted Endosomes through Interaction with p62 Mol. Cell. Biol., May 1, 1998; 18(5): 3069 - 3080. [Abstract] [Full Text] |
||||
![]() |
M. Szamel, A. Appel, R. Schwinzer, and K. Resch Different Protein Kinase C Isoenzymes Regulate IL-2 Receptor Expression or IL-2 Synthesis in Human Lymphocytes Stimulated via the TCR J. Immunol., March 1, 1998; 160(5): 2207 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu, W. Ning, R. Dantzer, G. G. Freund, and K. W. Kelley Activation of Protein Kinase C-{zeta} and Phosphatidylinositol 3'-Kinase and Promotion of Macrophage Differentiation by Insulin-Like Growth Factor-I J. Immunol., February 1, 1998; 160(3): 1393 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saharinen, N. Ekman, K. Sarvas, P. Parker, K. Alitalo, and O. Silvennoinen The Bmx Tyrosine Kinase Induces Activation of the Stat Signaling Pathway, Which Is Specifically Inhibited by Protein Kinase Cdelta Blood, December 1, 1997; 90(11): 4341 - 4353. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bandyopadhyay, M. L. Standaert, L. Zhao, B. Yu, A. Avignon, L. Galloway, P. Karnam, J. Moscat, and R. V. Farese Activation of Protein Kinase C (alpha , beta , and zeta ) by Insulin in 3T3/L1 Cells. TRANSFECTION STUDIES SUGGEST A ROLE FOR PKC-zeta IN GLUCOSE TRANSPORT J. Biol. Chem., January 24, 1997; 272(4): 2551 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Kieser, T Seitz, H S Adler, P Coffer, E Kremmer, P Crespo, J S Gutkind, D W Henderson, J F Mushinski, W Kolch, et al. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells. Genes & Dev., June 15, 1996; 10(12): 1455 - 1466. [Abstract] [PDF] |
||||
![]() |
M. M. Municio, J. Lozano, P. Sánchez, J. Moscat, and M. T. Diaz-Meco Identification of Heterogeneous Ribonucleoprotein A1 as a Novel Substrate for Protein Kinase C [IMAGE] J. Biol. Chem., June 30, 1995; 270(26): 15884 - 15891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |